Lack of evidence for polymorphism in metoprolol metabolism.

This publication has 17 references indexed in Scilit:

• Oxidation Phenotype — A Major Determinant of Metoprolol Metabolism and Response
  New England Journal of Medicine, 1982
• BETA-BLOCKERS AND DRUG OXIDATION STATUS
  The Lancet, 1982
• The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: Metoprolol, nadolol, and acebutolol
  Biopharmaceutics & Drug Disposition, 1982
• Variability of beta-blocker pharmacokinetics in young volunteers
  European Journal of Clinical Pharmacology, 1982
• The pharmacokinetics of acebvutolol in man, following the oral administration of acebutolol hcl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.)
  Biopharmaceutics & Drug Disposition, 1981
• The effect of age on the pharmacokinetics of metoprolol and its metabolites.
  Published by Wiley ,1981
• Clinical Pharmacokinetics of Metoprolol
  Clinical Pharmacokinetics, 1980
• Polymorphism of carbon oxidation of drugs and clinical implications.
  BMJ, 1978
• Metabolism of metoprolol‐(³H) in man, the dog and the rat
  Acta Pharmacologica et Toxicologica, 1975
• Comparative bioavailability and effect studies on metoprolol* administered as ordinary and slow‐release tablets in single and multiple doses
  Acta Pharmacologica et Toxicologica, 1975